Neil W. Scott

Neil W. Scott

Auto-generated profile, based on publicly available information

Neil W. Scott

Biostatistics and Health Data Science, University of Aberdeen, Aberdeen, UK

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2002 in Controlled Clinical Trials
Verified
Journal Article
Closed access
NSNeil W Scott
Neil W Scott
GMGladys C McPherson
Gladys C McPherson
CRCraig R Ramsay
Craig R Ramsay
MCMarion K Campbell
Marion K Campbell

20 January 2003 in Cochrane Database of Systematic Reviews
Verified
Journal Article
Closed access
PDF file
KMKirsty McCormack
Kirsty McCormack
NSNeil Scott
Neil Scott
PGPeter M.N.Y.H Go
Peter M.N.Y.H Go
SRSue J Ross
Sue J Ross
AGAdrian Grant
Adrian Grant
CTCollaboration the EU Hernia Trialists
Collaboration the EU Hernia Trialists

1 January 2016 in Journal of Clinical Epidemiology
Verified
Journal Article
Open access
JGJohannes M. Giesinger
Johannes M. Giesinger
JKJacobien M. Kieffer
Jacobien M. Kieffer
PFPeter M. Fayers
Peter M. Fayers
MGMogens Groenvold
Mogens Groenvold
MPMorten Aa. Petersen
Morten Aa. Petersen
NAN.K. Aaronson
N.K. Aaronson
To further evaluate the higher order measurement structure of the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire Core 30 (QLQ-C30), with the aim of generating a summary score. Using pretreatment QLQ-C30 data (N = 3,282), we conducted confirmatory factor analyses to test seven previously evaluated higher order models. We compared the summary score(s) derived from the best performing higher order model with the original QLQ-C30 scale scores, using tumor stage, performance status, and change over time (N = 244) as grouping variables. Although all models showed acceptable fit, we continued in the interest of parsimony with known-groups validity and responsiveness analyses using a summary score derived from the single higher order factor model. The validity and responsiveness of this QLQ-C30 summary score was equal to, and in many cases superior to the original, underlying QLQ-C30 scale scores. Our results provide empirical support for a measurement model for the QLQ-C30 yielding a single summary score. The availability of this summary score can avoid problems with potential type I errors that arise because of multiple testing when making comparisons based on the 15 outcomes generated by this questionnaire and may reduce sample size requirements for health-related quality of life studies using the QLQ-C30 questionnaire when an overall summary score is a relevant primary outcome.

1 February 2006 in Journal of Bone and Joint Surgery
Verified
Journal Article
Closed access
JKJ.F. Keating
J.F. Keating
AGA. Grant
A. Grant
MMM. Masson
M. Masson
NSN.W. Scott
N.W. Scott
JFJ.F. Forbes
J.F. Forbes
Background: Orthopaedic surgeons vary in their management of displaced intracapsular fractures of the hip in healthy older patients. The aim of this investigation was to determine the functional, clinical, and resource consequences of three different types of surgical treatment. Methods: The study was a multicenter randomized controlled trial. Reduction and fixation was compared with bipolar hemiarthroplasty with cement and total hip replacement with cement. Participating surgeons elected to randomize their patients to be treated with either one of the three types of procedures or with either fixation or bipolar hemiarthroplasty. Functional outcomes were measured with a hip-rating questionnaire and the EuroQol health status measure. Clinical outcomes included mortality and complications. The direct health service costs were compared. Participants were followed up for two years. Results: Two hundred and seven patients were randomized to be treated with one of the three operations, and ninety-one were randomized to be treated with either fixation or bipolar hemiarthroplasty. There were no differences in the mortality rates among the treatment groups. The rate of secondary surgery was highest in the fixation group (39% compared with 5% in the group treated with bipolar hemiarthroplasty and 9% in the group treated with total hip replacement). The fixation group had the worst hip-rating-questionnaire and EuroQol scores at four and twelve months. The total hip replacement group had significantly better functional outcome scores at twenty-four months than the other two groups. Although fixation was initially the least costly procedure, this short-term advantage was eroded by significantly higher costs for subsequent hip-related hospital admissions. Conclusions: Arthroplasty is more clinically effective and cost-effective than reduction and fixation in healthy older patients with a displaced intracapsular fracture of the hip. The long-term results of total hip replacement may be better than those of bipolar hemiarthroplasty. Level of Evidence: Therapeutic Level II. See Instructions to Authors for a complete description of levels of evidence.

11 January 2005 in British Journal of Cancer
Verified
Journal Article
Open access
LML Macdonald
L Macdonald
JBJ Bruce
J Bruce
NSN W Scott
N W Scott
WSW C S Smith
W C S Smith
WCW A Chambers
W A Chambers
Post-mastectomy pain syndrome (PMPS) is a recognised complication of breast surgery although little is known about the long-term outcome of this chronic pain condition. In 1996, Smith et al identified a prevalence rate of PMPS of 43% among 408 women in the Grampian Region, Northeast Scotland. The aim of this study was to assess long-term outcome at 7–12 years postoperatively in this cohort of women, to describe the natural history of PMPS and impact of pain upon quality of life. Chronic pain and quality of life were assessed using the McGill Pain Questionnaire (MPQ) and Short Form-36 (SF-36). Of 175 women reporting PMPS in 1996, 138 were eligible for questionnaire follow-up in 2002. Mean time since surgery was 9 years (s.d. 1.8 years). A response rate of 82% (113 out of 138) was achieved; 59 out of 113 (52%) women reported continued PMPS and 54 out of 113 (48%) women reported their PMPS had resolved since the previous survey in 1996. Quality of life scores were significantly lower in women with persistent PMPS compared to those women whose pain had resolved. However, for women with persistent PMPS, SF-36 scores had improved over time. Risk factors for persistent PMPS included younger age and heavier weight. This study found that, of women reporting PMPS in 1996, half of those surveyed in 2002 continued to experience PMPS at a mean of 9 years after surgery.

1 August 2007 in European Journal of Cancer
Verified
Journal Article
Closed access
MKMichael Koller
Michael Koller
NANeil K. Aaronson
Neil K. Aaronson
JBJane Blazeby
Jane Blazeby
ABAndrew Bottomley
Andrew Bottomley
LDLinda Dewolf
Linda Dewolf
KWKaren West
Karen West